The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

Want to learn what a Biomarker is?

Cambridge Consultants Joe Corrigan, head of business development for intelligent health and James Blakemore Ph.D., Senior Consultant, Strategy Group will be presenting on the progression of digital biomarkers in clinical trials and beyond.

The Progression of Digital Biomarkers in Clinical Trials and Beyond

As a developer of connected pharmaceutical aerosol devices, and beyond into diagnostics and industrial systems, Cambridge Consultants is well placed to observe the progression of industry trends in digital adoption and digital biomarkers. As digitisation takes hold, and access to healthcare-focused digital information management systems becomes more interconnected, there is greater scope for development of digital health solutions. Digital clinical trials improve patient access, recruitment and retention, can speed data collection and analytics and allows for precision interventions. Because of the high value of the segment, development of digital biomarkers has attracted investment from pharma, medical device and consumer device backgrounds. The overall trend is from digitisation of information toward transformation of the patient care paradigm through real-time diagnostics and molecular biomarkers with analytics that can be acted on by the patient or caregiver.

The Covid-19 pandemic has accelerated investment in the development of telehealth solutions and the development of decentralised clinical trials. From a technology perspective this means that connected systems have been a priority, allowing new entrants to gain a foothold with connectivity solutions. More precise, less invasive diagnostics, along with artificial intelligence/machine learning and edge compute platforms, are permitting data acquisition to progress from narrowband to broadband allowing greater insight to be derived from clinical trials and the potential for modified interventional strategies at the point of care.

Date | 10 September 2021

Time | 9:00 - 11:00am US ET / 2:00 - 4:00pm BST

Speakers:

  • Joe Corrigan, head of business development for intelligent health, Cambridge Consultants
  • James Blakemore Ph.D., Senior Consultant Strategy Group, Cambridge Consultants

Related content

More events


Speaker

A3 Business Forum

31st Jan 2022 - 2nd Feb 2022
Signia by Hilton Orlando Bonnet Creek, Orlando, Florida

Join us in Orlando, Florida to meet automation manufacturers, system integrators, distributors, manufacturers' reps, machine builders, end users and start-ups to discuss the trends in robotics, vision & imaging, artificial intelligence and much more.

Webinar

Medtech Connect Osaka 2022 | The challenges to realising next generation therapeutics

10th Feb 2022
Virtual

The race to bring the promise of advanced therapies to Japanese patients

Webinar

Realizing the vision of LEO satellite connectivity

17th Feb 2022
Virtual

Excitement reverberates around the prospect of ubiquitous connectivity, with cellular coverage direct from satellites to standard IoT devices and ultimately, even smartphones. The big question is – how do we as an industry ensure such promise is turned to commercial reality? Join our webinar to learn more and hear from those leading this race. 

ExhibitorPanel discussion

World Agri-Tech Innovation Summit 2022

22nd Mar 2022 - 23rd Mar 2022
San Francisco Marriott Marquis, Hybrid Event

Join us in San Francisco for the first time in three years. Growers, agribusiness leaders, technology pioneers and investors come together to exchange insights, be inspired, and identify future partners.